Ciprofloxacin hydrochloride price index

Ciprofloxacin hydrochloride price December 2025 and outlook (see chart below)

• India:US$17.94/KG, -0.1% down

Business Analytiq assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, or timeliness.

Ciprofloxacin hydrochloride price index

This post is a summary of the Ciprofloxacin hydrochloride price developments. The price developments of Ciprofloxacin hydrochloride are expressed in US$ prices converted FX rates applicable at the time when the price was valid. Ciprofloxacin hydrochloride price index developments are calculated from multiple separate sources of data to ensure statistical accuracy.

The outlook for Ciprofloxacin hydrochloride prices is generated from different inputs including:

• Very recent price developments of immediate cost drivers of Ciprofloxacin hydrochloride prices
• Recent price developments of underlying feedstocks which drive the price of Ciprofloxacin hydrochloride
• Market futures for both cost drives and feedstocks of Ciprofloxacin hydrochloride prices
• Adjustment of current supply/demand imbalances in the Ciprofloxacin hydrochloride market
• Longer term trends in likely demand conditions

What is Ciprofloxacin hydrochloride and what is it used for

Ciprofloxacin hydrochloride is the hydrochloride salt form of ciprofloxacin, a broad-spectrum fluoroquinolone antibiotic. It kills or stops the growth of many Gram-negative and some Gram-positive bacteria and is used to treat infections such as urinary tract infections, certain respiratory and gastrointestinal infections, bone and joint infections, skin and soft tissue infections, and specific serious infections (including as part of post-exposure anthrax treatment in some settings).

How is Ciprofloxacin hydrochloride produced

Ciprofloxacin is made by multi-step organic synthesis that builds the quinolone core (commonly from substituted benzoyl precursors) and then installs the piperazine side chain; the final product is converted to the hydrochloride salt by acidification and crystallisation. Modern routes include high-yield two-step or continuous-flow syntheses that aim to shorten reaction times and reduce waste; many published methods and patent filings describe variations of these steps and salt-formation/filtration procedures used for the API.

How large is the global market for Ciprofloxacin hydrochloride

Market estimates vary by source and definition (API vs finished formulations), but recent market reports place the global ciprofloxacin/ciprofloxacin-HCl market in the low billions of USD: several reports estimate roughly USD 1.2–1.9 billion in the early 2020s, with forecasts commonly projecting mid-single-digit CAGR growth to values in the ~USD 2.0–3.0+ billion range by the early-to-mid 2030s. Differences reflect whether the figure covers just the API, finished dose forms, or regional pricing and patent/generic dynamics.

Where is it produced

Ciprofloxacin hydrochloride is manufactured worldwide but the bulk of generic API production is concentrated in major active pharmaceutical ingredient (API) hubs — notably India and China — with a range of generic and branded manufacturers supplying global markets. Large pharmaceutical and API companies (for example: well-known Indian generic houses and several multinational firms) produce or trade ciprofloxacin HCl; commercial supplier directories and industry databases list dozens of API manufacturers and exporters across India, China, Europe and elsewhere.